Best Alzheimer's and Dementia Research Grants in American Samoa

American Samoa organizations that run Alzheimer’s and dementia research education programs for high school students, undergraduates, or science teachers can access funding through the National Institutes of Health, with awards up to US $200,000. Grants support summer, hands-on AD/ADRD research experiences plus complementary STEM education enrichment activities to build the future research workforce.

Grants from the National Institutes of Health help American Samoa institutions build postbaccalaureate research education programs in Alzheimer’s disease and related dementias. Eligible organizations can request up to US $400,000 to provide 1–2 year, mentored, hands-on AD/ADRD research experiences and professional development for recent graduates preparing for advanced research careers.

Graduate-level researchers pursuing dementia and Alzheimer’s disease translational research in American Samoa and other U.S. territories can receive predoctoral fellowship support through the National Institutes of Health. This NIA program funds training for candidates from diverse backgrounds to build skills for team-based research on AD/ADRD prevention, detection, treatment, and care.

Postdoctoral researchers from diverse backgrounds conducting translational Alzheimer's and dementia research in American Samoa can receive support for advanced research training. US Dept. of Health & Human Services: National Institutes of Health (NIH) funds projects spanning population studies to behavioral, social, diagnostic, and treatment-related research, excluding independently led clinical trials but allowing mentored clinical trial research experiences.

Eligible U.S. institutions training predoctoral and postdoctoral researchers in Alzheimer’s and dementia translational science can apply for support to build interdisciplinary training programs. With a mission to advance dementia research capacity, the National Institutes of Health provides American Samoa–serving programs with funding to develop skills in data science, disease biology, behavioral research, and drug discovery for AD/ADRD.

Undergraduate-focused higher education institutions in American Samoa conducting biomedical research, including dementia and Alzheimer’s disease studies, can apply for NIH Academic Research Enhancement Awards. Eligible baccalaureate-granting schools with limited prior NIH funding may receive up to US $375,000 to support small-scale projects that engage undergraduates and strengthen their research environment.

Grants supporting aging, Alzheimer’s disease, and related dementia research and academic leadership in American Samoa and other U.S. territories can access up to US $150,000 through the National Institutes of Health. Established investigators use these awards to build institutional research capacity, infrastructure, mentorship, and career development activities in aging and AD/ADRD fields without leading independent clinical trials.

Research institutions studying aging, Alzheimer’s disease, or related dementias in American Samoa and other eligible U.S. locations can apply for upcoming National Institutes of Health R01 funding to investigate mechanisms linking olfactory decline with these conditions. Projects may use human or animal models and diverse methods, including cellular, molecular, imaging, physiological, omics, and NAMs approaches.

Early-career investigators focused on Alzheimer’s and related dementias in American Samoa can pursue pathway-to-independence funding to build translational research careers. Focused on dementia and Alzheimer’s disease, the National Institutes of Health invites diverse researchers to gain advanced skills for studies spanning population research, prevention, diagnostics, treatment, and care, with awards around Approximately US $100,000.

Researchers studying dementia and Alzheimer’s disease, including those in American Samoa, can apply for National Institutes of Health R01 funding to investigate cerebellar roles in cognitive and affective function. Projects may use human or animal models, secondary data analyses, or explore cerebellar-targeted interventions to enhance cognitive reserve or delay Alzheimer’s and related dementias.

Grants support postdoctoral researchers from diverse backgrounds conducting Alzheimer’s and dementia research, including those based in American Samoa, as they transition to independent faculty roles. Grants from National Institutes of Health help investigators obtain mentored research experience and independent NIH support in Alzheimer’s disease and related dementias without leading their own clinical trials.

Research institutions conducting Alzheimer's and dementia translational research in American Samoa and other U.S. jurisdictions can apply for institutional training support to develop predoctoral and postdoctoral researchers. Grants from US Dept. of Health & Human Services: National Institutes of Health will fund interdisciplinary programs building skills in data science, disease biology, behavioral research, and drug discovery for AD/ADRD.

Research institutions and qualified organizations conducting Alzheimer’s and dementia drug discovery can apply for National Institutes of Health support, including projects in American Samoa. This upcoming U01 opportunity will fund rigorous preclinical validation of novel AD/ADRD targets and early-stage discovery of small molecules, biologics, and emerging therapeutic modalities; investigators are encouraged to prepare collaborative proposals.

Research institutions and collaborative teams studying neurodegeneration mechanisms in Alzheimer’s disease-related dementias can apply for National Institutes of Health Centers without Walls support, including those in American Samoa. Funding backs large, interdisciplinary consortia using advanced technologies and clinical or human data to uncover ADRD mechanisms, biomarkers, and therapeutic targets; applications are not yet being solicited.

Research institutions studying how environmental and neural exposome factors affect Alzheimer’s disease-related dementias can apply for National Institutes of Health support, including projects based in American Samoa. This program funds mechanistic, translational, and human subjects research on exposomic contributions to ADRD pathology, progression, resilience, and neurological health disparities across the lifespan.

Research institutions and teams conducting dementia and Alzheimer’s disease studies in American Samoa can apply for National Institutes of Health support to functionally validate new therapeutic targets. This phased funding backs development of technologies, models, and protocols, then cross-validation of target modulation across experimental modalities to advance Alzheimer’s disease-related dementias treatments.

The BJA FY 2026 Kevin and Avonte Program aims to reduce the injuries and fatalities of individuals with dementia and developmental disabilities who wander from safe environments. This funding opportunity supports law enforcement and public safety agencies in implementing locative technologies to track missing individuals and develop programs that enhance safety and facilitate rescues, ultimately ensuring the well-being of vulnerable populations.

The National Institute on Aging (NIA) is inviting applications for the Alzheimer's Drug-Development Program (U01 Clinical Trial Optional). This initiative seeks to support pre-clinical and early-stage clinical development of innovative drug candidates aimed at preventing Alzheimer's disease or treating its symptoms. The program encourages collaboration among researchers and aims to enhance the therapeutic pipeline for AD through targeted approaches. This notice allows potential applicants time to prepare robust projects.

Research institutions studying human consciousness and its role in conditions like dementia, Alzheimer’s disease, delirium, sleep disorders, and brain injury, including those in American Samoa, can apply for up to US $600,000 from the National Institutes of Health. Funding supports a national interdisciplinary network to develop shared standards, infrastructure, and training for consciousness-related neuroscience research.

Research institutions and teams conducting Alzheimer’s and dementia genetics research, including those in American Samoa, can apply for U24 funding to develop and operate a secure, cloud-based data and computing platform for NIAGADS. Grants from the National Institutes of Health help expand access to large-scale AD/ADRD genomic data, analysis tools, and training resources.

The Dementia Care and Brain Degenerative Diseases Grant, offered by the Sephardic Home For The Aged Foundation, aims to support innovative projects enhancing care and quality of life for older adults affected by dementia. Eligible organizations must be 501(c)3 nonprofits in operation for at least two years. The Foundation prioritizes proposals focusing on dementia care, promoting collaboration and resource access for aging individuals. Interested applicants should submit a Letter of Inquiry through the online application system.

The Alzheimer’s Association Research Fellowship for All (AARFA) Program aims to support early career researchers dedicated to advancing the understanding and treatment of Alzheimer’s and other dementias. By providing funding to postdoctoral researchers under established mentorship, the program fosters the development of independent scientists. It encourages applications from individuals in underrepresented groups, recognizing the value of diverse perspectives in scientific inquiry and clinical practice, ultimately contributing to the fight against dementia.

The Alzheimer’s Association Clinician Scientist Fellowship for All (AACSFA) aims to support the training of clinician scientists in Alzheimer’s and other dementias. This program encourages applications from individuals in underrepresented groups, emphasizing the value of diverse representation in clinical and scientific fields. The fellowship is designed for professionals with patient contact or diagnostic roles, fostering advancements in dementia research and care.

The Anne & Irving Brodsky Innovation Grant, offered by the Alzheimer's Foundation of America, provides $25,000 to support innovative programs that enhance the lives of individuals affected by Alzheimer's disease and related conditions. This grant is exclusively available to AFA nonprofit member organizations, with funding directed towards essential program expenses such as staff training, administrative costs, and necessary supplies. The initiative aims to foster advancements in care and support for families dealing with Alzheimer's.

The Project Lifesaver International Grant by the Alzheimer’s Foundation of America aims to fund programs that prevent wandering and enhance public safety for individuals with dementia-related illnesses. This grant supports public safety agencies that are members of AFA and Project Lifesaver International, focusing on essential training, supplies, and community outreach. Grants are awarded biannually, promoting better care and safety for individuals living with Alzheimer’s disease and related dementias.

The DoW Alzheimer’s Transforming Care Award aims to support innovative clinical research and trials enhancing dementia care for individuals with Alzheimer’s disease. This funding opportunity encourages collaborative partnerships and requires preliminary data, focusing on interventions that do not solely test pharmacological solutions. Community collaboration is essential, and studies leveraging existing cohorts, including those with younger participants, are encouraged. The award supports both new and existing partnerships among principal investigators.

The FY26 Alzheimer’s Research Program's Transforming Diagnosis Award (TrDA) promotes innovative research aimed at overcoming significant barriers to accurate diagnosis and monitoring of Alzheimer's disease. This award encourages community collaboration and requires preliminary data. It supports studies leveraging existing cohorts, especially those including individuals aged 65 and younger. The TrDA also offers a partnership option for multiple principal investigators, fostering collaborative research efforts while ensuring at least one independent investigator meets eligibility criteria.